BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 4, 2001
View Archived Issues
Phase II trial to compare two ciprofloxacin formulations for urinary tract infections
Read More
FDA accepts for review Picovir NDA for use in the common cold
Read More
AtheroGenics begins phase I trial of AGIX-4207 for rheumatoid arthritis
Read More
ICN acquires promising liver-targeting hepatitis B compound
Read More
FDA approves Dermagraft living human dermal substitute
Read More
Chromax dietary supplement undergoes clinical testing for treatment of depression
Read More
Marine sponge-derived compound with antiinflammatory properties
Read More
Sch-351125: an orally bioavailable anti-HIV CCR5 antagonist
Read More
Human monoclonal antibody targeting IL-15 advances to clinical trials in RA patients
Read More
Molsidomine reduces upregulated prostacyclin synthase mRNA in hypoxic pulmonary hypertension
Read More
Antinociceptive effects demonstrated for the synthetic cannabinoid HU-210
Read More
Pharmacological profile of PTK-787/ZK-222584, a new, orally active angiogenesis inhibitor
Read More
Divalproex as a treatment strategy for alcohol withdrawal syndrome
Read More
Progenics licenses drug in clinical development for reducing peripheral opioid side effects
Read More
NIH supports development of inhaled gene therapy for hemophilia B
Read More
Topiglan well tolerated by both males and their female partners during intercourse
Read More
GSK develops highly potent and selective COX-2 inhibitors
Read More
VEGF receptor tyrosine kinase inhibitors and their use in cancer
Read More
New oxazolidinone antibacterial agents with broad-spectrum activity
Read More
Aventis patents new series of bone resorption inhibitors
Read More
P&G compounds reportedly useful for treating and preventing ischemia-reperfusion injury
Read More
AstraZeneca team discovers inhibitors of iNOS useful for inflammation and pain
Read More
Inhibitors of beta-amyloid aggregation claimed by JT for use in dementia
Read More
